Alejandro Alva, MD

Alejandro Alva, MD, offers insights on the use of prescription digital therapeutics for substance use disorders at the Southern Florida Psychiatry Conference.

Clinician discusses the importance of maximizing medication doses and trial periods for effectively managing tardive dyskinesia at the Southern California Psychiatry Conference.

In advance of the June 4 FDA Advisory Committee Meeting on MDMA-assisted therapy, we sat down with Alejandra Alva, MD, to get his first impressions.